Analytical Data
-
Gene name
RPL39
- Application
-
Alternative Names
RPL39; 60S ribosomal protein L39; Large ribosomal subunit protein eL39
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P62891
-
Expression Region
1-51 aa
-
AA Sequence
MSSHKTFRIK RFLAKKQKQN RPIPQWIRMK TGNKIRYNSK RRHWRRTKLG L
-
Molecular Weight
6.4 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
RPL39, a member of the ribosomal protein family, plays a crucial role in the assembly and function of the ribosome, the cellular machinery responsible for protein synthesis. Studies have indicated that RPL39 is not only integral to ribosome biogenesis but also has implications in various cellular processes, including cell growth and proliferation. Abnormal expression of RPL39 has been associated with several types of cancers, suggesting its potential role as a biomarker and therapeutic target in oncological research. Additionally, emerging evidence points to RPL39's involvement in stress response pathways and its influence on the regulation of mRNA translation under adverse conditions. To further investigate its functions and mechanisms, researchers focus on producing recombinant RPL39, allowing for detailed biochemical and structural studies. Understanding the role of RPL39 in the ribosome's function and its broader implications in cellular homeostasis could provide valuable insights into the development of novel cancer therapies and enhance our knowledge of ribosome biology in health and disease. Thus, the elucidation of RPL39's properties through recombinant technology is a significant step toward uncovering its multifaceted roles in cellular dynamics and potential clinical applications.
